CVS Health Co. (NYSE:CVS) Position Lessened by Horizon Bancorp Inc. IN

Horizon Bancorp Inc. IN decreased its holdings in shares of CVS Health Co. (NYSE:CVSFree Report) by 24.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,430 shares of the pharmacy operator’s stock after selling 804 shares during the quarter. Horizon Bancorp Inc. IN’s holdings in CVS Health were worth $109,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. MidAtlantic Capital Management Inc. bought a new position in CVS Health in the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in CVS Health during the third quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health in the 3rd quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC bought a new stake in shares of CVS Health during the third quarter valued at approximately $32,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

CVS opened at $51.54 on Tuesday. The company has a fifty day simple moving average of $51.76 and a 200 day simple moving average of $56.49. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market cap of $64.86 billion, a P/E ratio of 13.08, a P/E/G ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVSGet Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the prior year, the company earned $2.21 EPS. The company’s revenue was up 6.3% on a year-over-year basis. On average, research analysts expect that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 5.16%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent research reports. TD Cowen increased their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Barclays decreased their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $68.71.

Read Our Latest Analysis on CVS

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Read More

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.